Ontology highlight
ABSTRACT: Background
Concomitant tricuspid annuloplasty (TA) during surgery for degenerative mitral regurgitation remains debated. A recent Cardiothoracic Surgical Trials Network trial demonstrated a reduction in tricuspid regurgitation with concomitant TA, with no mortality or quality of life benefit and a significantly higher risk of permanent pacemaker placement. We sought to quantify the rate of TA in eligible patients after publication of these trial results.Methods
Using a regional collaborative, we identified all patients between 2017 and 2023 with degenerative mitral regurgitation undergoing mitral valve repair or replacement. We included only those patients with moderate tricuspid regurgitation. Those with endocarditis, primary tricuspid regurgitation, severe tricuspid regur
SUBMITTER: Wisniewski AM
PROVIDER: S-EPMC12712165 | biostudies-literature | 2025 Dec
REPOSITORIES: biostudies-literature